Blue Owl Capital Holdings LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $303 Million distributed in 141 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $33.7M, Pliant Therapeutics, Inc. with a value of $33.7M, Owl Rock Capital Corp with a value of $27.4M, Larimar Therapeutics, Inc. with a value of $27.3M, and Proshares Ultrapro Qqq with a value of $23.6M.

Examining the 13F form we can see an increase of $62.5M in the current position value, from $241M to 303M.

Blue Owl Capital Holdings LP is based out at New York, NY

Below you can find more details about Blue Owl Capital Holdings LP portfolio as well as his latest detailed transactions.

Portfolio value $303 Million
Healthcare: $182 Million
Technology: $48.3 Million
Financial Services: $36.1 Million
ETFs: $23.6 Million
Consumer Cyclical: $7.5 Million
Real Estate: $4.62 Million
Energy: $995,000
Industrials: $106,000
Other: $53,000

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 141
  • Current Value $303 Million
  • Prior Value $241 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 98 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Blue Owl Capital Holdings LP Portfolio

Follow Blue Owl Capital Holdings LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Owl Capital Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Owl Capital Holdings LP with notifications on news.